GO
Loading...

Barclays PLC

More

  • April 10- Shares of auto-lender Ally Financial Inc fell as much as 3 percent in their market debut on Thursday, taking the shine off the biggest U.S. Treasury, which sold 95 million shares at $25 each, the low end of the expected price range of $25- $28.

  • Ally Financial shares fall in debut Thursday, 10 Apr 2014 | 9:40 AM ET

    April 10- Shares of bailed out auto-lender Ally Financial Inc fell 3 percent in their market debut, valuing the company at about $11.7 billion in the biggest U.S. Detroit- based Ally's shares were trading at $24.25 shortly after the opening on the New York Stock Exchange.

  • *Copper, iron ore see double-digit month-on-month growth in March. SHANGHAI, April 10- China's imports of iron ore and copper soared in March from the previous month in anticipation of higher seasonal demand in the world's top metals consumer, though crude oil shipments dropped after three months of high inbound volumes.

  • *Premier Li says no problem if growth a little below target. BOAO/ BEIJING, April 10- Chinese Premier Li Keqiang ruled out major stimulus to fight short-term dips in growth, even as big falls in imports and exports data reinforced forecasts that the world's second-largest economy has slowed notably at the start of 2014..

  • SINGAPORE, April 10- Brent futures eased towards $107 a barrel on Thursday as weak China trade data stoked demand growth concerns and investors booked profits after gains of 2 percent over the past two days.

  • NEW YORK, April 9- The Pimco Total Return Fund, the world's largest bond fund, cut its holdings of U.S. government-related securities and mortgages for the second straight month in March on continued bets that the Federal Reserve will conclude bond purchases this year, data from the firm's website showed on Wednesday.

  • April 9- Ally Financial Inc's initial public offering has been priced at $25 per share, an underwriter said, valuing the bailed-out auto lender at about $12.04 billion. Ally's IPO is the biggest U.S. offering so far this year, eclipsing that of Santander Consumer USA Holdings Inc and IMS Health Holdings Inc..

  • April 9- Younger investors may have drawn the right conclusion about the great financial crisis- that they were scammed- but their defensive reaction will simply add self-inflicted wounds to existing injuries.

  • European shares edge higher, travel firms in demand Wednesday, 9 Apr 2014 | 3:19 AM ET

    Appetite for stocks was boosted by a recovery on Wall Street overnight, although rising gold and oil prices demonstrated the market's vulnerability to continued tensions in Ukraine, where the United States accused Russian agents on Tuesday of stirring separatist unrest.

  • *Defaulters Ecuador, Greece prepare bonds; Pakistan, Zambia raise 10- yr cash. *After Q1 bond issuance tops $100 bln, second wave of riskier emerging credits.

  • Barry Knapp joins BlackRock in fixed income Tuesday, 8 Apr 2014 | 9:25 AM ET

    Barry Knapp is joining BlackRock to lead a new fixed income strategy team this summer, leaving Barclays.

  • High stakes bet? I should CoCo Tuesday, 8 Apr 2014 | 1:21 AM ET
    London's financial district, known as the Square Mile.

    The returns for convertible bonds or "CoCos" - a hybrid of debt and equity - can be high, but so too can the carnage be that they cause.

  • Sheridan Healthcare hires banks for IPO - WSJ Monday, 7 Apr 2014 | 11:46 PM ET

    April 7- Sheridan Healthcare Inc, a physician services company, has hired banks for an initial public offering, which may raise between $400 million and $500 million, the Wall Street Journal reported, citing people familiar with the matter.

  • BRUSSELS, April 7- Thirteen investment banks, including Citigroup, Goldman Sachs and Deutsche Bank, will fight EU charges of blocking exchanges' access to the credit derivatives market at a hearing next month, three people familiar with the matter said on Monday.

  • April 7- Specialty pharmaceuticals company Mallinckrodt Plc will buy drugmaker Questcor Pharmaceuticals Inc for about $5.6 billion to gain access to its lucrative drug to treat multiple sclerosis, Acthar Gel.

  • April 7- Specialty pharmaceuticals company Mallinckrodt Plc will buy drugmaker Questcor Pharmaceuticals Inc for about $5.6 billion to gain access to its lucrative drug to treat multiple sclerosis, Acthar Gel. This acquisition, Mallinckrodt's second deal in less than two months, highlights its efforts to tap into the fast-growing specialty drugs market.

  • WELLINGTON, April 7- New Zealand's Commerce Commission said on Monday that its recent investigation of banks in New Zealand was related to the possibility of foreign exchange rate manipulation.

  • *FTSE 350 companies seen paying £75.1 bn in dividend, highest since 2008. *Banks to drive increase as Lloyds, Barclays resume payouts. Companies in the FTSE 350 index are expected to pay 75.1 billion pounds in ordinary dividends in the next financial year, up 4.4 percent annually.

  • Square secures credit in 'low hundreds of millions' Sunday, 6 Apr 2014 | 2:36 PM ET
    Square, a credit card reader, is arranged on an Apple iPhone.

    Mobile payments company Square has secured a new revolving credit facility as the burgeoning startup seeks more permanent capital

  • Abu Dhabi Islamic Bank to buy Barclays UAE retail Sunday, 6 Apr 2014 | 10:43 AM ET

    DUBAI, United Arab Emirates— Abu Dhabi Islamic Bank says it has reached an agreement to buy the retail banking operations of Barclays Bank in the United Arab Emirates for 650 million dirham, or roughly $177 million. The Abu Dhabi Islamic Bank says the acquisition, which is subject to UAE Central Bank approval, would result in around 110,000 new customers.

Most Popular Video

Thursday, 17 Apr 2014 | 5:00 AM ET

Today is CNBC's 25th anniversary. There have been a lot of great moments in the network's history. Here are just a few.

Thursday, 17 Apr 2014 | 3:15 AM ET

Jonny Forsyth, global drinks analyst at Mintel, says China has been a "cash cow" for drink-makers, but the slowdown is having a big impact on sales.

Thursday, 17 Apr 2014 | 1:35 AM ET

CNBC's Helia Ebrahimi discusses the Co-Operative's troubled story from drug buying allegations against the former chairman, to big financial black holes.